Table 1 Mechanism of MSCs resistance to apoptosis.

From: The dual role of mesenchymal stem cells in apoptosis regulation

Pathways

Molecules

Mechanisms

Refs

Mitochondrial pathway

IL-6

Via the activation of the JAK-STAT3-Ref-1 and JAK-Stat3-Bcl-2/Bax-Caspase-3 pathways; Upregulate the mRNA expression of Cyclin D and Bcl-xl

[28, 37]

PGE2

Via ERK1/2 and GSK3beta phosphorylation to increase Bcl-2 and decrease Bax expression

[29]

TGF-β

Through TGF-β/Bax singling pathway

[30]

miR-29a-3p

Regulate Bcl-2 and Bcl-xl genes

[31]

miR-125b-5p

Repress the protein expression of p53, leading to the modulation of Bcl-2 and Bax to inhibit apoptosis

[32]

miR-93

Through targeting the HDAC4/Bcl-2 axis

[33]

miR-150-5p

Via targeting Bax

[34]

lncRNA-UCA1

Target miR-873 via sponging, reducing the latter’s suppressive effects on its target XIAP, and this translated into AMPK phosphorylation and increased level of the antiapoptotic protein Bcl-2

[35]

 

Enhance translocation of Bcl-2 to the nucleus

[36]

CXCL12

Reduce caspase-3 activation and modulate the expression of the antiapoptotic protein Bcl-xl

[38]

 

Upregulate p-AKT and p-Bad by PI3K-AKT-Bad pathway

[39]

Death receptor pathway

 

Suppress the protein expression levels of macrophage-related factors inducible nitric oxide synthase and TNF-α

[40]

miR-21-5p

Modulate Fas-L expression

[41]

miR-17

Regulate BRD4-mediated EZH2/TRAIL axis to essentially inhibit LPS-induced macrophages inflammation and apoptosis

[42]

 

Via TLR3-regualted MAPK and NF-κB signaling pathway

[43]

Endoplasmic reticulum pathway

HGF

Via a microenvironment-dependent paracrine HGF/c-Met signaling mechanism to suppress ERS and its downstream pro-inflammatory and pro-apoptotic consequences

[44]

TNF-inducible gene 6 protein

Suppress ERS-induced apoptosis and NF-κB activity

[45]

miR-21

By alleviating ERS and inhibiting p38 MAPK

[46]

 

By improving Myc expression through both stromal cell-derived factor 1 signal and contact effect

[47]

Upstream regulatory pathways

miR-29b-3p

Activate the PI3K/AKT pathway by carrying miR-29b-3p into neurons and silencing PTEN, thus reducing neuronal apoptosis

[49]

miR-223

Inhibit the apoptosis of neurons in vitro by targeting PTEN, thus activating the PI3K/Akt pathway

[50]

miR-144

Inhibit cell apoptotic injury in hypoxic conditions by delivering miR-144 to cells, where it targets the PTEN/AKT pathway

[51]

miR-486-5p

By suppressing PTEN expression, activating the PI3K/AKT signaling pathway, and subsequently inhibiting the apoptosis of injured cardiomyocytes

[52]

lncRNA-KLF3-AS1

Inhibit autophagy and apoptosis of IL-1beta-treated chondrocyte through PI3K/Akt/mTOR signaling pathway

[53]

miR-132-3p

Downregulate the target protein RASA1, while upregulate the expression of Ras and the downstream PI3K phosphorylation

[54]

 

Involve NRG-1/HER2, MAPK, PI3K/AKT, p-JNK/JNK, and p-STAT/STAT signaling pathways

[162]

 

Involve G-CSF/PI3K/AKT pathway

[163]

 

By inhibiting apoptosis of skin cells and promoting their proliferation through activating PI3K/AKT signaling pathway

[164]

miR-369-3p

Downregulate the expression of YAF2, inhibit the stability of PDCD5/p53, and reduce the apoptosis of ovarian granulosa cells

[55]

miR-644-5p

Inhibit the apoptosis of ovarian granulosa cell by targeting p53

[56]

miR-125b-5p

Suppress the expression of the pro-apoptotic genes p53 and BAK1 in cardiomyocytes

[57]

miR-455-3p

Target the MEKK1-MKK4-JNK signaling pathway

[58]

miR-19a

Target SOX6, activate AKT, and inhibit JNK3/caspase-3 activation

[59]

 

By inhibiting p38/MAPK pathway

[60,61,62]

Others

 

By transferring mitochondria

[63, 64]

 

Increase the mitochondrial membrane potential and alleviate compression-induced mitochondrial damage to alleviate compression-mediated nucleus pulposus cell apoptosis

[65]

 

Retard mitochondria damage and cell apoptosis by an AMPK-PGC1-alpha axis

[66]

 

Promote mitophagy and inhibit apoptosis and pyroptosis of renal tubular epithelial cells in kidney tissues by upregulating SIRT1/Parkin

[67]

 

By reduce mitochondrial reactive oxygen species overproduction, decrease the accumulation of mitochondrial fragmentation, restore ATP generation and upregulate mitophagy

[68]

miR-486

Reduce Smad1 expression by target regulating Smad1 whose reduction could inhibit mTOR activation, leading to the increase of autophagy and the reduction of podocyte apoptosis

[69]

 

Through regulating Notch2/mTOR/autophagy signaling

[70]

miR-217

Target EZH2, and EZH2 bound to the FOXO3 promoter and consequently downregulate its expression, which restrain NPC apoptosis and ECM degradation by stimulating cell autophagy

[71]

ALKBH5

ALKBH5-mediated FIP200 mRNA demethylation in enhancing autophagy and reducing apoptosis

[72]

 

Reduce pyroptosis in the injured liver and promote the expression of those factors related to liver regeneration, while they can inhibit the NF-κB pathway and activate the wnt/beta-catenin pathway

[73]

 

Increase FOXO3a expression to enhance mitophagy, therefore protecting microglia from I/R-induced pyroptosis and alleviating subsequent neuronal injury

[74]

miR-539-5p

Suppresses pyroptosis through NLRP3/caspase-1 signal

[75]

circ-HIPK3

By regulate miR-421, resulting in increased expression of FOXO3a, leading to inhibition of pyroptosis and release of IL-1beta and IL-18

[76]

miR-223-3p

Restrict cardiac inflammation, pyroptosis, and dysfunction by disrupting FOXO3/NLRP3 axis

[77]

miR-26a-5p

Degrade METTL14 and thus decrease NLRP3

[78]

circ-003564

Attenuate inflammasome-related pyroptosis via delivering circ-003564

[79]

  1. MSCs mesenchymal stem cells, IL Lnterleukin, JAK Janus kinase, STAT signal transducer and activator of transcription, Ref-1 Redoxfactor-1, Bcl-2 B-cell lymphoma-2, PGE2 prostaglandin E2, ERK extracellular regulated protein kinases, GSK3β glycogen synthase kinase 3, TGF-β transforming growth factor-beta, HDAC histone deacetylase, miR micro RNA, XIAP X-linked inhibitor of apoptosis protein, AMPK Adenosine 5′-monophosphate-activated protein kinase, CXCL12 C-X-C motif chemokine 12, PI3K phosphatidylinositol 3-kinase, TNF-α Tumor necrosis factor-alpha, Fas-L Fas ligand, BRD4 bromodomain-containing protein 4, EZH2 enhancer of zeste homolog 2, TRAIL TNF-related apoptosis inducing ligand, LPS lipopolysaccharide, TLR3 Toll-like receptor 3, MAPK mitogen-activated protein kinase, HGF hepatocyte growth factor, ERS endoplasmic reticulum stress, PTEN phosphatase and tensin homolog, RASA1 Ras GTPase activating protein 1, NRG-1 neuregulin-1, HER2 human epidermal growth factor receptor-2, G-CSF granulocyte colony-stimulating factor, YAF2 YY1 associated factor 2, PDCD5 programmed cell death 5, BAK1 Bcl-2 antagonist/killer 1, MEKK1 MAPK kinase 1, MKK4 MAPK kinase 4, JNK c-Jun N-terminal kinase, SOX6 SRY-box transcription factor 6, PGC1 peroxisome proliferator-activated receptor gamma coactivator 1, SIRT1 Sirtuin 1, EZH2 enhancer of zeste homolog 2, FOXO3 forkhead box O3, NPC nucleus pulposus cells, ECM: extracellular matrix, ALKBH5 ALKB homolog 5, FIP200 FAK-family interacting protein of 200 kDa, NLRP3 NOD-like receptor thermal protein domain associated protein 3, METTL14 methyltransferase-like protein 14.